“…Several types of Ca 2ϩ entry and Ca 2ϩ release channels have been implicated in such remodeling in various cancer types (FIGURE 2, blue color). Among them are ORAI1 and STIM1 SOC components (78,136,218,260,308,420,558,569); TRP members TRPV6 (44,136,289,290,420), TRPC1, TRPC3, TRPC4 and TRPC6 (15, 19, 85, 117-119, 247, 458, 460, 485, 487, 557), TRPM2 (556), TRPM6/7 (117,190,475,554,560); Ca v family members (58,381,562); as well as IP 3 R (436,481) and RyR (3) ER release channels. Most of the relevant data, however, were obtained by comparing respective channels mRNA expression in normal and cancer tissues and assaying proliferative activity of related cancer cell lines in the in vitro setting in response to pharmacological or siRNA-mediated impairment of channels function and/or expression.…”